Latest News & Updates
Breaking News
1 day ago
Vaibhavi M.
Other trending news you may like to read
Sanofi Gains FDA Approval for Subcutaneous Isatuximab-irfc Delivered via CirCLIQ On-Body Device
FDA approves Sanofi's subcutaneous isatuximab-irfc via CirCLIQ OBDS for three multiple myeloma indications, raising combination product manufacturing requirements.
Vaibhavi M.
AB Science Suspends Three Masitinib Trials to Concentrate Resources on ALS and AML Programs
AB Science discontinues three masitinib trials, directing resources to AML and ALS programs amid regulatory closeout and amendment obligations.
Vaibhavi M.
Merck Gains FDA Approval for IV and Subcutaneous Pembrolizumab Each with Enfortumab Vedotin in Muscle Invasive Bladder Cancer
FDA approves Merck's IV and subcutaneous pembrolizumab each with enfortumab vedotin for all MIBC patients eligible for cystectomy.
Vaibhavi M.
India Tightens Controls on High-Alcohol Medicinal Formulations to Curb Misuse
India tightens regulatory controls on high-alcohol medicinal formulations, raising compliance obligations for manufacturers and importers.
Vaibhavi M.
